{"title":"Multi-attribute method analysis of therapeutic monoclonal antibodies using an automated sample preparation system","authors":"Noritaka Hashii , Chihiro Obata , Miho Okada , Shota Nakamura , Keisuke Fukazawa , Shio Watanabe , Akiko Ishii-Watabe","doi":"10.1016/j.jpba.2024.116542","DOIUrl":null,"url":null,"abstract":"<div><div>The multi-attribute method (MAM) has attracted increased attention as an alternative strategy for evaluating structural heterogeneity using conventional separation techniques such as ion-exchange chromatography and capillary electrophoresis of therapeutic monoclonal antibodies (mAbs). One of the remaining challenges for the practical use of the MAM is reliable and robust continuous monitoring. In this study, we successfully established an automated sample preparation system as a solution to this issue. Through method optimization, we confirmed that the peptide purification step using a solid-phase extraction column, which is usually performed after the digestion step, was not mandatory and that the addition of methionine as an oxidation inhibitor was able to significantly reduce artificial oxidation. Importantly, the use of our system enabled high-precision analysis for targeted peptide monitoring without relying on the operator’s knowledge and experience with peptide mapping using liquid chromatography/mass spectrometry (LC/MS). Our system could also be useful as a platform approach for targeted peptide monitoring in MAM workflow of traditional IgG-type mAbs. Furthermore, using common samples that were prepared using the automated system, we assessed the compatibility of LC/MS system in the targeted peptide monitoring via a collaborative study with MS vendors. The results showed that there was no significant difference in the mass accuracy, repeatability of the peak retention time and variations of intermediate precision of the measurement values among the four LC/MS systems, suggesting sufficient compatibility among the LC/MS systems. MAM system using our automated sample preparation method, which had high intermediate precision, will be useful for release and stability testing as well as characterization and manufacturing process development.</div></div>","PeriodicalId":16685,"journal":{"name":"Journal of pharmaceutical and biomedical analysis","volume":"253 ","pages":"Article 116542"},"PeriodicalIF":3.1000,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pharmaceutical and biomedical analysis","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0731708524005843","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0
Abstract
The multi-attribute method (MAM) has attracted increased attention as an alternative strategy for evaluating structural heterogeneity using conventional separation techniques such as ion-exchange chromatography and capillary electrophoresis of therapeutic monoclonal antibodies (mAbs). One of the remaining challenges for the practical use of the MAM is reliable and robust continuous monitoring. In this study, we successfully established an automated sample preparation system as a solution to this issue. Through method optimization, we confirmed that the peptide purification step using a solid-phase extraction column, which is usually performed after the digestion step, was not mandatory and that the addition of methionine as an oxidation inhibitor was able to significantly reduce artificial oxidation. Importantly, the use of our system enabled high-precision analysis for targeted peptide monitoring without relying on the operator’s knowledge and experience with peptide mapping using liquid chromatography/mass spectrometry (LC/MS). Our system could also be useful as a platform approach for targeted peptide monitoring in MAM workflow of traditional IgG-type mAbs. Furthermore, using common samples that were prepared using the automated system, we assessed the compatibility of LC/MS system in the targeted peptide monitoring via a collaborative study with MS vendors. The results showed that there was no significant difference in the mass accuracy, repeatability of the peak retention time and variations of intermediate precision of the measurement values among the four LC/MS systems, suggesting sufficient compatibility among the LC/MS systems. MAM system using our automated sample preparation method, which had high intermediate precision, will be useful for release and stability testing as well as characterization and manufacturing process development.
期刊介绍:
This journal is an international medium directed towards the needs of academic, clinical, government and industrial analysis by publishing original research reports and critical reviews on pharmaceutical and biomedical analysis. It covers the interdisciplinary aspects of analysis in the pharmaceutical, biomedical and clinical sciences, including developments in analytical methodology, instrumentation, computation and interpretation. Submissions on novel applications focusing on drug purity and stability studies, pharmacokinetics, therapeutic monitoring, metabolic profiling; drug-related aspects of analytical biochemistry and forensic toxicology; quality assurance in the pharmaceutical industry are also welcome.
Studies from areas of well established and poorly selective methods, such as UV-VIS spectrophotometry (including derivative and multi-wavelength measurements), basic electroanalytical (potentiometric, polarographic and voltammetric) methods, fluorimetry, flow-injection analysis, etc. are accepted for publication in exceptional cases only, if a unique and substantial advantage over presently known systems is demonstrated. The same applies to the assay of simple drug formulations by any kind of methods and the determination of drugs in biological samples based merely on spiked samples. Drug purity/stability studies should contain information on the structure elucidation of the impurities/degradants.